Skip to content

Author

Andrea Orsi

We have 3 of 28 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Adjuvanted Influenza Vaccines Versus Other Influenza Vaccines in Adults Aged ≥60 Years: A Systematic Review and Meta-Analysis of Relative Effectiveness for Preventing Influenza-Related Hospitalization

Background/Objectives: Seasonal influenza vaccines have been developed to reduce the risk of severe complications in older adults, who are at increased risk of influenza-related morbidity and mortality. This study aimed to synthesize the available evidence on the comparative effectiveness of MF59-adjuvanted versus high...

Daniela Amicizia, F. Marchini, I. Schenone et al. · 0 citations
Open access Sep 2026

Coverage and appropriateness of influenza vaccination in adults ≥ 60 y: Provider contribution and adherence to Italian national recommendations

Evaluating the 2023/24 and 2024/25 influenza vaccination campaigns in Liguria (Italy) reveals a persistent mismatch between national recommendations and real-world clinical practice and only 65% and 73% among ≥65 y individuals received enhanced vaccines.

Daniela Amicizia, F. Grammatico, E. Massaro et al. · 0 citations
Review Open access Sep 2026

mRNA-based seasonal influenza vaccines: an overview of immunogenicity, efficacy, and safety

Whether mRNA platforms offer incremental benefits over enhanced formulations (such as high-dose, adjuvanted, or recombinant vaccines), which are the preferred options in some countries for older adults, remains to be established.

A. Domnich, Andrea Orsi · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.